Dyne Therapeutics Inc DYN:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/24/21 EST
20.23quote price arrow up+1.05 (+5.47%)
Volume
296,490
52 week range
15.60 - 32.31

...

Loading . . .

KEY STATS

  • Open19.33
  • Day High20.99
  • Day Low19.04
  • Prev Close20.23
  • 52 Week High32.31
  • 52 Week High Date01/20/21
  • 52 Week Low15.60
  • 52 Week Low Date10/19/20
  • Market Cap1.041B
  • Shares Out51.45M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.34
  • P/E (TTM)-59.34
  • Fwd P/E (NTM)-11.12
  • EBITDA (MRQ)-25.071M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)2.71%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Dyne Therapeutics Inc News

There is no recent news for this security.

Latest DYN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Dyne Therapeutics Inc. is a biotechnology company focused on developing therapeutics for patients with genetically driven diseases. The Company’s FORCE platform therapeutics consists of an oligonucleotide payload that it designs to target the genetic basis of the disease. With its FORCE platform, the Company has the flexibility to deploy different types of oligonucleotide payloads with specific mechanisms of action that modify target functions. Using its FORCE platform, the...
Jason Rhodes
Chairman
Joshua Brumm
President
Susanna High
Chief Operating Officer
Gene Kim
Vice President - Finance
Address
830 Winter Street
Waltham, MA
02451
United States